AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| JCC | Ann:Continuous Disclosure Query and Response (Price Sensitive) | 29/03/18 | 0 | 91 | |||
|
|||||||
| JCC | Ann:Government Grant for SkyWay (Price Sensitive) | 26/03/18 | 0 | 117 | |||
|
|||||||
| JCC | Ann:2018 Half Yearly Report (Price Sensitive) | 28/02/18 | 0 | 101 | |||
|
|||||||
See All Discussions
NSX News